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There is no consensus as to whether mesial temporal lobe epilepsy (MTLE) leads to executive function deﬁcits. In this study,
we adopted an extensive neuropsychological test battery and assessed diﬀerent executive functions in chronic, unilateral MTLE.
PerformanceofMTLEpatientswascomparedwiththatofhealthypeersandwithnormativedata.SeveralMTLEpatientshadscores
below cut-oﬀ or below the 10th percentile of normative data. Scores of the whole patient group were overall in the average range of
normative data. Relative to controls, MTLE patients performed poorly in tests of working memory, cognitive ﬂexibility, categorical
verbal ﬂuency, set-shifting, categorization, and planning. These ﬁndings raise an important methodological issue as they suggest
that executive function deﬁcits in chronic MTLE may be individually variable and that their assessment should include diﬀerent
tests. Deﬁcits in chronic MTLE are not limited to temporal lobe functions, such as memory, but may extend to extra temporal
cognitive domains, such as executive functions.
1.Introduction
Mesial temporal lobe epilepsy (MTLE) is possibly the
most frequent form of epilepsy [1] and is associated with
overt or subtle structural abnormalities in the hippocam-
pus, parahippocampal gyrus, and amygdala [2]. Recent
investigations have suggested that functional and structural
abnormalities in MTLE may extend beyond the temporal
lobes. Volume reduction has been observed in extratemporal
areas such as thalamus, caudate nuclei, lenticular nuclei,
corpus callosum, and frontal lobes (for a review, see [3]).
Alterations of frontotemporal white matter tracts [4]a n d
of neurotransmitter systems [5] have also been reported.
Metabolicchangeshavebeenobservednotonlyinmesialand
lateral temporal areas, but also in the prefrontal cortex [6]
and in subcortical structures [7, 8]. Thalamus, basal ganglia,
and frontal lobes are part of corticosubcortical circuits that
are involved in the regulation of motor functions, behavior,
and cognitive functions such as set-shifting, planning, and
inhibitory control [9, 10]. As increasing evidence points to
functional and structural alterations of these corticosub-
cortical circuits, it may be expected that MTLE patients
experience executive function deﬁcits.
The term “executive functions” refers to high-order cog-
nitive functions which allow adaptation to nonroutine sit-
uations such as novel, conﬂicting, or complex tasks [11, 12].
Planning, set-shifting, strategic behavior, response initiation,
and response inhibition are some of the cognitive functions
that may be listed under this umbrella term. Executive
function deﬁcits are often found in association with frontal
lobe damage [13, 14]. However, recent neuropsychological
investigations as well as neuroimaging studies have pointed
to a distributed brain network, which encompasses frontal
areasaswellasposteriorareas(e.g.,parietalassociationareas:
[15]; cerebellum: [16]) and subcortical structures (e.g., basal
ganglia: [17]; thalamus: [18]). Executive function deﬁcits
may be found in a large number of neurological pathologies,
in diﬀuse brain damage, and in focal brain damage [11,
12]. Single-case analyses of brain-damaged patients have
shown that executive function deﬁcits may have diﬀerent2 Epilepsy Research and Treatment
clinical manifestations and that performance on executive
function tests may be dissociated with deﬁcits observed on
some tests and not on others [11, 12]. Executive function
deﬁcits may have important consequences on the patient’s
autonomy and severely compromise the quality of life.
Given the multicomponent aspect of executive functioning,
its systematic assessment needs to cover several cognitive
processes.
Chronic MTLE may aﬀect cognitive and emotional
processing [19–21]. Compared with healthy controls, MTLE
patients often show reduced episodic memory and diﬃcul-
tiesinlearningnewinformation[22,23].Recentstudieshave
also reported diﬃculties in decision making [24, 25]. There
are mixed results regarding executive functioning in chronic
MTLE. Some studies have reported reduced performance for
MTLE patients as compared with controls [26–28]; others
have found no relevant diﬀerences [22, 24]. As, in most
studies, only a single test or a very short test battery has
been used to assess executive functioning in MTLE, it may
be possible that deﬁcits have been overlooked in some cases.
Also, no speciﬁc assessment of diﬀerent executive functions
has been done.
Studies that have used the Wisconsin Card Sorting Task
(WCST) [42] have found signiﬁcant diﬀerences between
MTLE patients and controls, pointing to abstraction, cate-
gorization, and set-shifting deﬁcits in MTLE (e.g., [24, 26–
28]; see also [43]). Studies that have screened for deﬁcits
in working memory [22, 24], inhibitory control [24, 28],
verbal ﬂuency [22, 28], or cognitive ﬂexibility [22, 24]
have obtained heterogeneous ﬁndings, making it diﬃcult
to conclude whether and to what extent MTLE patients
presentexecutivefunctiondeﬁcits.Inconsistentﬁndingshave
also been reported with regard to the eﬀect of seizure
lateralization. Giovagnoli [26] found that patients with
left-sided MTLE are more impaired than patients with
right-sided MTLE on the WCST, whereas Corcoran and
Upton [28, 44] reported the opposite pattern of results.
Other investigations found no signiﬁcant eﬀect of seizure
lateralization on executive functioning [22, 45].
This study aimed at investigating executive functioning
in a group of chronic, unilateral MTLE patients. Diﬀer-
ently from previous studies, we used an extensive battery
of neuropsychological tests and assessed diﬀerent aspects
of executive functioning (verbal attention, verbal working
memory, psychomotor speed, cognitive ﬂexibility, verbal
ﬂuency, set-shifting, categorization, inhibition, and plan-
ning). In this study, we compared performance of MTLE
patients with that of healthy peers as well as with normative
data. In separate analyses, we also controlled for possible
eﬀects of seizure lateralization (left-sided MTLE versus
right-sided MTLE), structural abnormality (hippocampus
versus amygdala), and antiepileptic drug therapy (AED),
which has been documented to signiﬁcantly aﬀect cognitive
performance [46–49]. A correlation analysis also examined
the association of executive function performance with age
at seizure onset and epilepsy duration.
Following previous reports on deﬁcits of TLE patients
in single executive function tests, we expected the MTLE
patients to perform poorly relative to the healthy controls in
the more comprehensive neuropsychological test battery. As
epilepsy in the dominant hemisphere may have detrimental
eﬀects on language processing, we also expected the left-
sided MTLE patients to perform poorly relative to the right-
sided MTLE patients on verbal ﬂuency tests. Finally, we
hypothesized that executive function deﬁcits are enhanced
in the patients with the earlier onset epilepsy and the longer
disease duration.
2. Methods
2.1. Participants. We examined prospectively 28 consecu-
tive patients with unilateral MTLE (12 women). (Patients
also performed tasks of decision making; these results are
described in [25].) Patients had pharmacoresistant, focal
epilepsy and were candidates for epilepsy surgery (age at
seizure onset: mean 21.5±14.5 years; disease duration: mean
18.2 ±15.2 years). Patients underwent a detailed clinical and
neurological examination including prolonged video-EEG
monitoring, high-resolution MRI, interictal SPECT or PET,
and a neuropsychological examination. They were seizure-
free for at least 48 hours before the neuropsychological
testing. Twenty-six patients were right hander [50]; two
were ambidextrous (only right-hander patients were taken
into consideration in the analysis of the eﬀect of seizure
lateralization).
Patients underwent a high-resolution 1.5-Tesla MRI with
T1-weighted spin echo and gradient echo 3D multiplanar
reconstruction images (with and without intravenous con-
trast application), axial and coronal T2-weighted turbospin
echo, T1 inversion recovery, T2-weighted fast ﬂuid atten-
uated inversion recovery (FLAIR), and diﬀusion-weighted
sequences. Coronal T2-weighted and FLAIR slices extended
1–3mm. Axial images were acquired with an angle parallel
to the long axis of the hippocampus. All but three MRI scans
were visually evaluated by two independent raters (G. K.,
F. K.) who were familiar with the radiological analysis of
the temporal lobe structures and were blinded to diagnosis.
Three patients underwent MRI outside our institution
following the above-mentioned protocol. For these three
patients, we obtained a detailed written description of the
mesial temporal structures. Agreement was achieved in all
but two cases (agreement: 93%). A third rater (E.T.) who
was blinded to diagnosis was consulted to resolve these two
cases. MRI revealed a clear unilateral abnormality in the left
mesial temporal lobe in 17 patients (LMTLE) and a clear
unilateral abnormality in the right mesial temporal lobe in
11 patients (RMTLE). Hippocampal abnormality was found
in 10 patients (hippocampus group = MTLE-HC), amygdala
abnormality in 11 patients (corpus amygdaloideum group =
MTLE-CA), and abnormalities aﬀecting both structures in 7
patients (see Figure 1 for examples of MRI features for the
three groups). The MTLE-HC group included patients with
MRIfeaturesofhippocampalsclerosis(atrophichippocampus
with missing internal three-layer architecture and increased
signal in T2 and FLAIR sequences) and hippocampal dyspla-
sia (hippocampus with distorted anatomy, with blurring of
white/grey matter interface, and increased signal in T2 and
FLAIR sequences). Amygdala was regarded as dysplastic if itEpilepsy Research and Treatment 3
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Figure 1: Examples of MRI features for the MTLE-HC group (a), the MTLE-CA group (b), and the MTLE-HC+CA group (c). (a) Upper
row: (A) FLAIR and (B) T2-weighted coronal images showing on the right side enlarged amygdala with increased MR signal in FLAIR and
T2-weighted sequences (dysplastic amygdala). Lower row: (C) FLAIR and (D) T2-weighted coronal images showing normal hippocampus;
R: right hemisphere; L: left hemisphere. (b) Upper row: (A) FLAIR and (B) T2-weighted coronal images showing on the right side atrophic
hippocampus with increased MR signal in FLAIR and T2-weighted sequences (hippocampal sclerosis). Lower row: (C) FLAIR and (D)
T2-weighted coronal images showing normal amygdala; R: right hemisphere; L: left hemisphere. (c) Upper row: (A) FLAIR and (B) T2-
weighted coronal images showing on the left side dysplastic hippocampus with increased MR signal in FLAIR and T2-weighted sequences.
Lower row: (C) FLAIR and (D) T2-weighted coronal images showing on the left side enlarged amygdala with increased MR signal in FLAIR
and T2-weighted sequences (dysplastic amygdala); R: right hemisphere; L: left hemisphere.
was larger than the contralateral side, if increased signal in
T2 and FLAIR sequences was observed, or both.
Fifteen patients received antiepileptic drug monotherapy
(carbamazepine, oxcarbazepine, lamotrigine, and levetirac-
etam); 13 patients were on polytherapy (carbamazepine,
lamotrigine, levetiracetam, oxcarbazepine, phenobarbital,
phenytoin, pregabalin, primidone, topiramate, valproate,
zonisamide; AED daily doses and serum levels are reported
for each patient in Table 4). The serum level was measured
within one day from the neuropsychological examination
in 24/28 patients (86%); in the remaining cases, the serum
level refers to the closest previous measurement (deviation
fromthedayoftheneuropsychologicalexamination:17to44
days). All but one patient had serum levels within standards.
The patient with the serum level for one antiepileptic drug
slightly above the normal range did not manifest signs of
intoxication. Also, neuropsychological performance did not
diﬀer between this patient and the patient group.
Twenty healthy volunteers (15 women) participated in
the study. They were recruited from the personnel of
the Innsbruck Medical University. Exclusion criteria for
participationwerehistoryofstroke,headtrauma,psychiatric
disorder, substance abuse, or neurological disorders which
may compromise cognition. Healthy participants and MTLE
patients were comparable in age (controls: mean 36.0 ± 13.0
years; MTLE patients: mean 40.3±11.3 years) and education
(controls: mean 11.4 ± 1.6 years; MTLE patients: mean 10.6
± 1.7 years). The present study was approved by the local
ethics committee. Informed consent was obtained from all
participants.
2.2. Neuropsychological Assessment. MTLE patients com-
pleted tests of verbal memory (learning, free recall, and
recognition—M¨ unchner Ged¨ achtnistest, MGT) [33], non-
verbal memory (subtest of the Visueller und Verbaler
Merkf¨ ahigkeitstest, VVM) [34], vocabulary [29], numeracy
[30, 31], mental complex calculation [32], and executive
functions (verbal attention and verbal working memory—
digit span tests of the Wechsler Memory Scale-Revised,
WMS-R [36]; psychomotor speed and cognitive ﬂexibility—
Trail Making Test-A and B, TMT-A and B [37]; cate-
gorical verbal ﬂuency, phonological verbal ﬂuency, and
verbal ﬂuency with alternating categories—subtests of
the Regensburger Wortﬂ¨ ussigkeitstest, RWT [38]; planning
and problem solving—Planungstest [41]; abstraction and
categorization—WCST [39]; inhibitory control—Go-NoGo
task adapted from [40]). MTLE patients also responded
to a questionnaire on anxiety and depression (Hospital
Anxiety and Depression Scale-Deutsche Version, HADS-D)
[35]. Controls were tested on vocabulary, numeracy, mental
complex calculation, and executive functions. The numeracy
test assesses basic probability and mathematical concept
understanding [30, 31].
2.3. Statistical Analysis. Data did not satisfy assumptions of a
normal distribution. Therefore, group diﬀerences were ana-
lyzed through nonparametric methods (Kruskal-Wallis H-
test, Mann-Whitney U-test). Signiﬁcance was set at α=.05.
ASpearman-rankcorrelationanalysiswascarriedoutfor
the MTLE group between executive function scores, age at
seizure onset, and epilepsy duration. The following executive
function variables were entered into the analysis: completed
categories (WCST), perseverative errors (WCST), digit span
backward (WMS-R), correct NoGo trials (Go-NoGo task),
sec in the TMT-B, total number of moves (Planungstest),
categorical verbal ﬂuency (RWT), and verbal ﬂuency with
alternating categories (set-shifting, RWT). Applying Bonfer-
roni correction for multiple correlations, signiﬁcance was set
at α = .003.
3. Results
3.1. Comparison with Normative Data. Median scores of
healthy controls were in the average range of normative data4 Epilepsy Research and Treatment
Table 1: Medians for scores in neuropsychological background tests as a function of group.
Max.
score
MTLE
patients
Healthy
controls P value
Patients deviating from norms
Mdn Mdn (n/N)( % )
Vocabulary [29] 37 28.5 31.0 .010 0/281 0
Numeracy [30, 31]1 1 8 . 0 ∗ 9.0 .004 15/282 54
Mental complex calculation [32] 24 11.0 14.0 .044 0/233 0
Verbal memory (MGT) [33]
Learning (5. trial) 16 13.0 — — 5/274 19
Immediate free recall 16 10.0 — — 11/274 41
Delayed free recall 16 12.0 — — 9/274 33
Recognition (corrected score) 16 15.0 — — 8/274 30
Nonverbal memory, immediate free recall
(VVM) [34] 31 18.0 — — 6/254 24
Anxiety (HADS-D) [35] 21 6.0 — — 5/285 18
Depression (HADS-D) [35] 21 2.0 — — 2/285 7
Digit span forward (WMS-R) [36] 12 7.0 7.5 .069 7/284 25
Digit span backward (WMS-R) [36]1 2 6 . 0 7 . 0 .013 8/284 29
Psychomotor speed (TMT-A) [37] 28.5 28.0 .379 3/284 11
Cognitive ﬂexibility (TMT-B) [37] 77.0 55.5 .007 12/284 43
Categorical verbal ﬂuency (RWT) [38] 23.5 27.0 .027 8/284 29
Phonological verbal ﬂuency (RWT) [38] 7.0 9.0 .080 12/274 44
Set-shifting (RWT) [38] 14.0 16.0 .004 2/284 7
Categorization (WCST) [39]
Completed categories 5 2.5 4.0 .010 7/284 25
Perseverative errors 10.0 6.0 .011 10/284 36
Go-NoGo task (adapted from [40])
Correct Go-trials 100 98.9 100.0 .038 2/284 7
Correct NoGo-trials 100 83.3 80.0 .892 3/284 11
Planning (Planungstest) [41]
Total number of moves 36.0 34.0 .009 2/284 7
Errors 0.0 0.0 — 1/284 4
Note: Group comparisons were carried out by means of Mann-Whitney U-test. Signiﬁcance was set at α = .05.
MTLE: mesial temporal lobe epilepsy; Mdn: Median; (1): cut-oﬀ IQ 85; (2): cut-oﬀ median 9; (3): cut-oﬀ 5; (4): cut-oﬀ 10th percentile; (5): cut-oﬀ 10; (∗):
slightly below cut-oﬀ;( — ) :n o ta v a i l a b l e .
inalltests(Tables1and2).TheMTLEpatients’medianscore
in the numeracy test was below cut-oﬀ. In other tests, the
MTLE patients’ median scores were in the average range of
normative data. The evaluation of individual scores revealed
several patients with performance below cut-oﬀ or below the
10th percentile of normative data (4–54%; Tables 1 and 2).
Regarding the executive function tests, 7 patients (25%)
performed below the 10th percentile of normative data in 5-
to-8 measures; 19 patients (68%) performed below the 10th
percentile in 1-to-3 measures. Only two patients showed a
normal performance in all measures.
3.2. Comparison of MTLE Patients with Healthy Controls.
Performance of MTLE patients was compared with that of
healthy controls by means of Mann-Whitney U-test. Group
diﬀerences were signiﬁcant in several neuropsychological
measures. MTLE patients obtained slightly lower vocabulary
scores, numeracy scores, and mental complex calculation
scores than controls (Table 1). Relative to controls, MTLE
patients also performed poorly in tests of verbal working
memory, cognitive ﬂexibility, categorical verbal ﬂuency, set-
shifting, categorization, and planning (Table 1). A signiﬁcant
group diﬀerence was also found in the Go-NoGo task.
MTLE patients responded less accurately than controls to
Go trials; groups did not diﬀer from each other in NoGo
trials. There were no signiﬁcant group diﬀerences in tests
of verbal attention, psychomotor speed, and phonological
verbal ﬂuency (Table 1).
3.3. Eﬀect of Seizure Lateralization
3.3.1. Comparison with Normative Data. RMTLE patients
had a median score slightly below cut oﬀ in the numeracy
test and a median score slightly below the 10th percentileEpilepsy Research and Treatment 5
Table 2: Medians for demographic information and scores in neuropsychological background tests as a function of seizure lateralization.
Max.
score
LMTLE patients
(n = 16)
RMTLE patients
(n = 10) P value
Mdn Mdn
Age (years) 46.0 35.5 .076
Education (years) 10.0 10.0 .075
Age at disease onset (years) 20.5 17.0 —
Disease duration (years) 11.5 14.0 —
Vocabulary [29] 37 27.0 29.0 .057
Numeracy [30, 31]1 1 8 . 5 ∗ 7.5∗ .014
Mental complex calculation [32] 24 11.5 9.0 .034
Verbal memory (MGT) [33]
Learning (5. trial) 16 13.0 15.0 —
Immediate free recall 16 9.5∗ 13.0 —
Delayed free recall 16 12.0 14.0 —
Recognition (corrected score) 16 15.0 14.0 —
Nonverbal memory, immediate free recall
(VVM) [34] 31 17.5 17.0 —
Anxiety (HADS-D) [35]2 1 5 . 5 7 . 0 —
Depression (HADS-D) [35]2 1 4 . 5 2 . 0 —
Digit span forward (WMS-R) [36] 12 7.0 6.0 .079
Digit span backward (WMS-R) [36]1 25 . 5 5 . 5 .047
Psychomotor speed (TMT-A) [37] 29.5 24.5 .691
Cognitive ﬂexibility (TMT-B) [37] 78.0 73.5 .018
Categorical verbal ﬂuency (RWT) [38] 22.5 27.0 .056
Phonological verbal ﬂuency (RWT) [38]5 . 0 ∗ 8.0 .012
Set-shifting (RWT) [38] 13.5 15.0 .011
Categorization (WCST) [39]
Completed categories 5 3.5 2.0∗ .027
Perseverative errors 10.0 10.0 .032
Go-NoGo task (adapted from [40])
Correct Go-trials 100 98.9 98.9 .059
Correct NoGo-trials 100 83.3 98.6 .878
Planning (Planungstest) [41]
Total number of moves 35.5 36.0 .029
Errors 0.0 0.0 —
Note: Group comparisons between LMTLE patients, RMTLE patients, and healthy controls were carried out by means of Kruskal-Wallis H-test. Signiﬁcance
was set at α = .05.
LMTLE: left-sided mesial temporal lobe epilepsy; RMTLE: right-sided mesial temporal lobe epilepsy; Mdn: Median; (∗): slightly below cut-oﬀ or below the
10th percentile of normative data; (—): not available.
in the WCST (Table 2). LMTLE patients had a median score
slightlybelowcutoﬀinthenumeracytestandamedianscore
slightly below the 10th percentile in the verbal memory test
(immediate free recall) and the phonological verbal ﬂuency
test(Table 2).Inothertests,themedianscoresofbothgroups
were in the average range of normative data.
3.3.2. Comparison with Healthy Controls. We performed
group comparisons by means of Kruskal-Wallis H-tests.
As indicated in Table 2, results were signiﬁcant in tests
of numeracy, mental complex calculation, verbal working
memory, cognitive ﬂexibility, phonological verbal ﬂuency,
set-shifting, categorization, and planning. Two-by-two com-
parisons were carried out by means of Mann-Whitney U-
tests. LMTLE patients obtained lower scores than RMTLE
patients in the phonological verbal ﬂuency test (z =− 2.06,
P = .041); other diﬀerences between the patient groups were
not signiﬁcant. Relative to healthy controls, LMTLE patients
performed poorly in tests of cognitive ﬂexibility (z =− 2.68,
P = .007), phonological verbal ﬂuency (z =− 2.81, P =
.004), set-shifting (z =− 3.01, P = .002), categorization
(completed categories: z =− 2.35, P = .019; perseverative
errors: z =− 2.46, P = .014), and planning (z =− 2.16, P =
.033). RMTLE patients obtained lower scores than healthy6 Epilepsy Research and Treatment
Table 3: Medians for demographic information and scores in neuropsychological background tests as a function of structural abnormality.
Max.
score
MTLE-HC patients
(n = 10)
MTLE-CA patients
(n = 11) P value
Mdn Mdn
Age (years) 47.0 34.0 .017
Education (years) 9.5 10.0 .001
Age at disease onset (years) 17.5 15.0 —
Disease duration (years) 30.5 6.0 —
Vocabulary [29] 37 25.0 29.0 .030
Numeracy [30, 31]1 1 7 . 0 ∗ 8.0∗ .059
Mental complex calculation [32] 24 9.0 12.5 .310
Verbal memory (MGT) [33]
Learning (5. trial) 16 12.0 14.0 —
Immediate free recall 16 6.5∗ 13.0 —
Delayed free recall 16 8.5∗ 14.0 —
Recognition (corrected score) 16 12.0∗ 16.0 —
Nonverbal memory, immediate free recall
(VVM) [34] 31 16.0 21.0 —
Anxiety (HADS-D) [35]2 1 9 . 5 6 . 0 —
Depression (HADS-D) [35]2 1 3 . 5 2 . 0 —
Digit span forward (WMS-R) [36] 12 6.0 7.0 .128
Digit span backward (WMS-R) [36]1 2 5 . 0 6 . 0 .031
Psychomotor speed (TMT-A) [37] 33.0 27.0 .866
Cognitive ﬂexibility (TMT-B) [37] 80.5 71.0 .078
Categorical verbal ﬂuency (RWT) [38] 20.0 27.0 .326
Phonological verbal ﬂuency (RWT) [38] 8.0 8.0 .746
Set-shifting (RWT) [38] 13.0 14.0 .187
Categorization (WCST) [39]
Completed categories 5 1.0∗ 4.0 .014
Perseverative errors 17.5∗ 9.0 .047
Go-NoGo task (adapted from [40])
Correct Go-trials 100 98.3 98.9 .646
Correct NoGo-trials 100 73.3∗ 86.7 .205
Planning (Planungstest) [41]
Total number of moves 36.0 36.0 .416
Errors 0.0 0.0 —
Note: Group comparisons between MTLE-HC patients, MTLE-CA patients, and healthy controls were carried out on residualized dependent variables by
means of Kruskal-Wallis H-test. Signiﬁcance was set at α = .05.
MTLE-HC: patients with hippocampal abnormalities; MTLE-CA: patients with abnormalities in the corpus amygdaloideum; Mdn: Median; (∗): slightly
below cut-oﬀ or below the 10th percentile of normative data; (—): not available.
controls in tests of numeracy (z =− 2.86, P = .005), mental
complex calculation (z =− 2.30, P = .019), verbal working
memory (z =− 2.33, P = .022), categorization (completed
categories: z =− 2.15, P = .035), and planning (z =− 2.24,
P = .028). Other diﬀerences between patient groups and
healthy controls were not signiﬁcant.
3.3.3. Further Comparisons between RMTLE Patients and
LMTLE Patients. Mann-Whitney U-tests indicated that
RMTLE patients and LMTLE patients were comparable in
terms of age at seizure onset and epilepsy duration. There
were also no signiﬁcant group diﬀerences in tests of verbal
memory, nonverbal memory, anxiety, and depression.
3.4. Eﬀect of Structural Abnormality
3.4.1. Comparison with Normative Data. MTLE-CA patients
scored slightly below cut-oﬀ in the numeracy test (Table 3).
MTLE-HCpatientsscoredbelowcut-oﬀinthenumeracytest
and below the 10th percentile in tests of verbal memory, cat-
egorization, and inhibitory control (Table 3). Other median
scores were in the average range of normative data for both
patient groups.Epilepsy Research and Treatment 7
3.4.2. Comparison with Healthy Controls. As the MTLE-HC
patients were older and had less education than both the
healthy controls and the MTLE-CA patients, we residualized
age and education on the dependent variables and then used
these measures in the analysis. Group comparisons were
performed by means of Kruskal-Wallis H-tests. There were
signiﬁcant group diﬀerences in tests of vocabulary, verbal
working memory, and categorization (Table 3). MTLE-HC
patients obtained lower scores than MTLE-CA patients in
the WCST (completed categories: z =− 1.97, P = .051).
Relative to healthy controls, MTLE-HC patients performed
poorly in tests of vocabulary (z =− 1.98, P = .005), verbal
working memory (z =− 2.68, P = .006), and categorization
(completed categories: z =− 2.75, P = .005; perseverative
errors: z =− 2.48, P = .012). Diﬀerences between MTLE-CA
patients and healthy controls were not signiﬁcant.
3.4.3. Further Comparisons between MTLE-HC Patients and
MTLE-CA Patients. As indicated by Mann-Whitney U-test,
MTLE-HC patients and MTLE-CA patients had comparable
age at seizure onset. The MTLE-HC group had longer
epilepsy duration than the MTLE-CA group (z =− 2.44, P =
.012). Diﬀerences between MTLE-HC patients and MTLE-
CA patients in tests of verbal memory, nonverbal memory,
anxiety, and depression were not signiﬁcant when residual-
ized scores were submitted to Mann-Whitney U-tests.
3.5. Eﬀect of Antiepileptic Drug Therapy. Patients on
monotherapy and patients on polytherapy had comparable
scores in all demographic, clinical, and neuropsychological
measures (Mann-Whitney U-tests, all P>. 05). The compar-
ison of individual scores with the patient group distribution
indicated that ﬁve patients had an outlier performance—
that is, below 2.5SD from the group mean—in some
memoryand executive functionmeasures.Outliercaseswere
evenly distributed between the monotherapy group and the
polytherapy group (see Table 4).
3.6. Correlation Analysis. There was a signiﬁcant correlation
between epilepsy duration and performance on the WCST
(completed categories, r =− .581, P = .002). The longer the
disease duration, the poorer the performance. No signiﬁcant
correlation was found between age at seizure onset and
performance on executive function tests. (An exploratory
analysis indicated that performance on nonexecutive func-
tion tests (vocabulary, memory, and complex numerical
processing) directly correlated with performance on exec-
utive function tests. However, these results did not survive
Bonferroni correction for multiple correlations. Neither
performance on executive function tests nor performance
on nonexecutive function tests correlated with anxiety and
depression scores.)
4. Discussion
This study used an extensive neuropsychological test battery
and assessed several aspects of executive functioning in
chronic,unilateralMTLEpatients.Performanceofacarefully
selected group of pharmacoresistant MTLE patients, who
were candidates for epilepsy surgery, was compared with
that of healthy peers as well as with normative data. Pos-
sible eﬀects of seizure lateralization, structural abnormality,
antiepileptic drug therapy, age at seizure onset, and epilepsy
duration were also analyzed.
Results indicated that both the MTLE group and the
healthycontrolgrouphadmedianscoresintheaveragerange
of normative data. However, there were signiﬁcant group
diﬀerences in several executive function measures. Relative
to healthy peers, MTLE patients performed poorly in tests
of verbal working memory, cognitive ﬂexibility, categorical
verbal ﬂuency, set-shifting, categorization, planning, and
inhibitory control. They performed comparably to healthy
controls in tests of verbal attention, psychomotor speed, and
phonological verbal ﬂuency. The evaluation of individual
scores corroborated the results of these group comparisons.
Several patients had scores below cut-oﬀ or below the
10th percentile of normative data. Also, almost one-third
of the patients had impairments in 5-to-8 measures of
executive functioning; two thirds had impairments in 1-to-3
measures. These ﬁndings raise an important methodological
issue as they suggest that executive function deﬁcits in
chronic MTLE may be individually variable and that their
assessment needs to include diﬀerent tests. We suggest
the use of an extensive neuropsychological test battery
which assesses diﬀerent aspects of executive functioning
(e.g., working memory, cognitive ﬂexibility, categorization,
inhibitorycontrol,andplanning).Asshownbythisstudy,the
use of a single task (e.g., Go-NoGo) is not suﬃcient for the
detection of executive function deﬁcits which may be highly
speciﬁc.
As a correlation analysis indicated, performance of
MTLE patients on the WCST inversely correlated with
epilepsy duration. Similar results were described by Kim et
al. [27], whereas Martin et al. [43] found no association
between performance on the WCST and epilepsy duration
or age at seizure onset. Black et al. [45] tested working
memory and executive functions in a large group of TLE
patients (the majority of patients had mesial temporal
lobe epilepsy). Results showed that age at seizure onset
and seizure frequency, which signiﬁcantly correlated with
epilepsy duration, were signiﬁcant predictors of the patients’
impairments. In this study, MTLE patients had intractable
epilepsy, and epilepsy duration ranged from few months to
several years. As the brain suﬀers for longer time from the
epileptic discharges [51], it seems likely that the cognitive
deﬁcits were more pronounced in the MTLE patients with
the longer disease duration.
Thenegativeeﬀectofepilepsydurationoncognitionmay
be related not only to the eﬀect of the epileptic seizures
themselves, but also to other factors including the long-term
antiepileptic drug therapy. All commonly used antiepileptic
drugs seem to have some behavioral and cognitive eﬀects,
with the patients on polytherapy being on average more
aﬀected than the patients on monotherapy [46–49]. For
example, phenytoin, phenobarbital, and valproate have been
related to decline in attention and psychomotor speed
(for a review, see [48]); also, patients taking topiramate
have been found to perform poorly on verbal ﬂuency [52]8 Epilepsy Research and Treatment
Table 4: Individual daily dose and serum level of the antiepileptic drug therapy.
Patient code Gender Age Education AED daily dose (mg) AED serum level (μg/ml) Outlier
P 1 m 35 10 PGB 600, PB 150 PGB 6.3, PB 11.1
P 2 m 34 10 LEV 2000, PHE 200 LEV 9.2, PHE 3.2
P 3 f 46 10 LTG 150, LEV 2000 LTG 2.0, LEV 27.4 a
P 4 f 48 9 LTG 400, PRM 500, ZNS 200 LTG 9.5, PB 12.0, PRM 10.4, ZNS 18.6 b, c, d
P 5 m 49 9 CBZ RD 1050 CBZ 3.8, CBZ Epoxid 0.6
P 6 f 44 12 CBZ RD 600 CBZ 7.7
P 7 m 46 10 CBZ 300 CBZ 3.4
P 8 m 20 13 OXC 900 OXC 0.4, 10-OH-Carbazepin 24.6
P 9 m 44 10 OXC 900, LEV 3000 OXC 0.2, 10-OH-Carbazepin 13.2, LEV 27.0
P 10 f 46 10 LEV 3000 LEV 47.9 e
P 11 m 37 13 CBZ 300 CBZ 0.0
P 12 m 33 13 CBZ RD 1200 CBZ 7.9
P 13 m 59 10 CBZ RD 200 CBZ 1.7, CBZ Epoxid 0.1 d, f
P 14 m 51 9 CBZ RD 1200, TPM 250 CBZ 10.1, TPM 4.5
P 15 f 24 10 CBZ 750 CBZ 8.6 a
P 16 f 54 9 LEV 1500 LEV 28.8
P 17 m 58 10 CBZ RD 800, ZNS 200 CBZ 10.1, CBZ Epoxid 1.2, ZNS 5.4
P 18 f 50 9 LEV 2000 LEV 32
P 19 f 18 12 LEV 3000, VPA RD 1250, ZNS 300 LEV 70.3, VPA 111.7, ZNS 22.4
P 20 m 38 10 LTG 300, PHE 200 LTG 3.9, PHE 5.4
P 21 f 36 10 LTG 200 LTG 10.7
P 22 m 24 16 LEV 3000, PGB 300 LEV 43.8, PGB 3.9
P 23 m 29 10 LEV 3000, PHE 400 LEV 27.5, PHE 19.9
P 24 f 35 13 CBZ RD 600 CBZ 5.8
P 25 m 57 10 CBZ RD 400, LEV 3000 CBZ 5.4, CBZ Epoxid 0.9, LEV 38.2
P 26 m 43 10 LEV 4000, OXC 2100 LEV 23.8, OXC 0.0, 10-OH-Carbazepin 24.3
P 27 f 30 10 LEV 1000 LEV 3.4
P 28 f 40 9 CBZ RD 1400 CBZ 12.2
AED: antiepileptic drug; m: male; f: female; CBZ: carbamazepine; LTG: lamotrigine; LEV: levetiracetam; OXC: oxcarbazepine; PB: phenobarbital; PHE:
phenytoin;PGB:pregabalin;PRM:primidone;TPM:topiramate;VPA:valproate;ZNS:zonisamide;a:outlierperformanceinplanning(totalnumberofmoves
or errors, Planungstest); b: outlier performance in categorical verbal ﬂuency (animals/min, RWT); c: outlier performance in categorization (perseverative
errors, WCST); d: outlier performance in verbal memory (recognition, MGT); e: outlier performance in verbal attention (digit span forward, WMS-R); f:
outlier performance in inhibitory control (correct NoGo trials, Go-NoGo task).
and categorization [27]. Compared with older antiepileptic
drugs, some of the new antiepileptic drugs have fewer
negative eﬀects on cognition [46, 48]. In this study, we found
that only few patients had an outlier performance relative
to performance of the whole patient group. None of the
medications seemed to have stronger eﬀects on cognition
than others. Also, there were no diﬀerences between patients
onmonotherapyandpatientsonpolytherapyinanymemory
or executive function measure. Although we cannot exclude
the possibility that small group diﬀerences between patients
on monotherapy and patients on polytherapy have been
missed because of the small sample group, these ﬁndings
may suggest that the antiepileptic drug therapy had no
relevant eﬀect on the executive function performance of
MTLE patients in this study.
Results of the comparison of left-sided MTLE patients
with right-sided MTLE patients showed no relevant group
diﬀerences with the only exception of a verbal ﬂuency
measure. Relative to right-sided MTLE patients, left-
sided MTLE patients performed poorly in a phonological
verbal ﬂuency test. These results are in line with other
investigations, which suggest no severe eﬀect of seizure
lateralization on executive functioning [22, 43, 45]. For
example, Tudesco et al. [22] tested MTLE patients with
unilateral hippocampal sclerosis. Comparably to this study,
they found that left-sided MTLE patients diﬀered from
right-sided MTLE patients in verbal ﬂuency tests, but not in
working memory and set-shifting tests.
There are competing hypotheses in the literature as to
the underlying mechanisms of executive function deﬁcits in
MTLE. A ﬁrst hypothesis (nociferous cortex hypothesis) [53]
proposesthatexecutivefunctiondeﬁcitsinMTLEresultfrom
thepropagationoftheepilepticdischargesfromthetemporal
lobe epileptic focus to the frontal lobes. There are white
matter tracts connecting the temporal lobes with the frontal
lobes [54, 55], and the epileptic discharges may propagateEpilepsy Research and Treatment 9
through these projections. According to a second hypothesis
(hippocampal contribution hypothesis) [28], executive fun-
ction deﬁcits in MTLE are related to dysfunction of the
hippocampus. Speciﬁcally, as the hippocampus is involved
in the retrieval of information from short-term memory, in
the formation of memory associations, and in learning new
information, the MTLE patients’ impairments in working
memory tasks as well as in other executive function tasks,
such as the WCST, that rely on such processes would result
from dysfunction of the hippocampus. Finally, increasing
evidence [3] points to the implication of extratemporal
functional and structural brain abnormalities—for example,
damage to frontosubcortical circuits, volume loss, or
metabolic changes in extratemporal regions—in the
executive function disorders of TLE patients. Our study
design does not allow us to precisely deﬁne the impact of
these diﬀerent factors on executive function performance.
Although an exploratory analysis indicated that patients
with hippocampal abnormalities (MTLE-HC) scored lower
than patients with amygdala abnormalities (MTLE-CA)
and healthy controls in the WCST, we may not exclude the
possibility that diﬀerent factors—propagation of epileptic
discharges, dysfunction of mesial temporal structures, and
extratemporal brain modiﬁcations—contributed to the
executive function disorders of MTLE patients in this study.
Other investigation methods—for example, functional
magnetic resonance imaging, voxel-based morphometry, or
diﬀusion tensor imaging—have to be employed, together
with neuropsychological testing, to address this question.
One could ask whether there is a speciﬁc pattern in
the executive function deﬁcits of MTLE patients. Miyake et
al. [56] used a latent variable analysis to investigate how
executive functions relate to each other. Results indicated
that functions such as updating, shifting, and inhibition
are clearly separable, but that they are not completely
independent from each other and seem to share some
common processes. Miyake et al. [56] proposed that the
central executive component of working memory [57]i sa
feasible candidate to account for some of the commonality
underlying diﬀerent executive functions [56, 58]. The central
e x e c u t i v ei sa na t t e n t i o n a lc o n t r o ls y s t e m ,w h i c ha l l o c a t e s
resources and coordinates and monitors short-term storage
p r o c e s s e sa sw e l la sm o r eg e n e r a lp r o c e s s e s[ 59]. Several
e x e c u t i v ef u n c t i o nt e s t sc l e a r l yl o a do nc e n t r a le x e c u t i v e
resources, as they require the maintenance of goal and
content information, the manipulation of memory represen-
tations, or the suppression of irrelevant information. In this
study,MTLEpatientshaddiﬃcultiesinparticularinthetests
that put high demands on attentional control resources (e.g.,
WCST, planning test, and verbal ﬂuency test with alternating
categories), whereas they performed relatively well in the less
demanding tests (e.g., digit span forward, TMT-A).
In sum, this study indicates that deﬁcits in chronic
MTLE are not limited to temporal lobe functions, such
as memory, but may extend to extratemporal cognitive
domains. Patients with chronic, pharmacoresistant MTLE
have executive function deﬁcits, and these deﬁcits are
individually variable. Executive functions such as cognitive
ﬂexibility, planning, and inhibitory control are essential
in everyday life. It is thus possible that MTLE patients
experience diﬃculties in everyday functioning, in particular
in those situations that are unknown and require rapid
adaptation or ﬂexible problem solving. This study adds
to the characterization of cognitive deﬁcits in MTLE and
suggeststheuseofacomprehensiveassessmentbatteryinthe
individual neuropsychological diagnosis.
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